Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1)
in the sixth column, expiration of approval, of row 296, Cyflufenamid, the date is replaced by ‘31 March 2023’;
(2)
in the sixth column, expiration of approval, of row 297, Fluopicolide, the date is replaced by ‘31 May 2023’;
(3)
in the sixth column, expiration of approval, of row 298, Heptamaloxyloglucan, the date is replaced by ‘31 May 2021’;
(4)
in the sixth column, expiration of approval, of row 300, Malathion, the date is replaced by ‘30 April 2022’.